Amylyx Pharmaceuticals Inc. (AMLX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Amylyx Pharmaceuticals In...

    NASDAQ: AMLX · Real-Time Price · USD
    10.14
    0.19 (1.91%)
    At close: Sep 05, 2025, 3:28 PM

    Amylyx Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 77.39M 170.2M 62.53M 50.19M
    Short-Term Investments
    		 99.11M 201.16M 284.42M 45.93M
    Long-Term Investments
    		 n/a n/a 719K 189K
    Other Long-Term Assets
    		 1.47M 46.38M 466K 3.44M
    Receivables
    		 447K 40.05M 15.31M n/a
    Inventory
    		 n/a 38.32M 9.77M n/a
    Other Current Assets
    		 12.48M 14.93M 10.11M 3.44M
    Total Current Assets
    		 189.43M 464.67M 382.13M 101.51M
    Property-Plant & Equipment
    		 2.73M 6.41M 8.13M 474K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 4.2M 52.79M 9.32M 4.1M
    Total Assets
    		 193.63M 517.45M 391.45M 105.61M
    Account Payables
    		 2.94M 22.06M 6.26M 4.37M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 1.52M n/a 2.04M n/a
    Other Current Liabilities
    		 23.95M 40.93M 21.04M n/a
    Total Current Liabilities
    		 28.41M 82.04M 46.61M 17.4M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a 35K
    Total Long-Term Liabilities
    		 463K 1.98M 4.24M 239.39M
    Total Liabilities
    		 28.87M 84.02M 50.85M 256.78M
    Total Debt
    		 1.98M 4.24M 6.28M n/a
    Common Stock
    		 7K 7K 7K 1K
    Retained Earnings
    		 -606.69M -304.95M -354.22M -155.84M
    Comprehensive Income
    		 -92K 197K -86K 9K
    Shareholders Equity
    		 164.76M 433.43M 340.61M -151.17M
    Total Investments
    		 99.11M 201.16M 284.42M 45.93M

    Add to Watchlist